Home > Analytics > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Intrinsic Value | Fundamental Analysis

BOM : 530019     NSE : JUBLPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : NA
Jun 29,2022
Price(EOD): ₹ 346.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 5,516.56 Cr
Value of ₹ 1 Lac invested in JUBILANT PHARMOVA
on Jun 29,2017 (price: ₹ 688.05)

₹ 1 L

₹ 0.50 L

1W : 5.1% 1M : -10% 1Y : -53%
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results
JUBILANT PHARMOVA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
JUBILANT PHARMOVA 5.1% -10% -53%
SUN PHARMACEUTICAL INDUSTRIES 1.6% -2.6% 23.2%
DIVIS LABORATORIES -2.2% -0.2% -14.5%
DR REDDYS LABORATORIES 1.6% -0.1% -17.5%
CIPLA 1.4% -4.9% -1.2%
GLAND PHARMA 1.7% -7.3% -17.1%
PIRAMAL ENTERPRISES 2.1% -12.2% -30.3%
CADILA HEALTHCARE 2.9% -5.9% -42.7%
TORRENT PHARMACEUTICALS -0.5% -0.3% -0.1%

FUNDAMENTAL ANALYSIS OF JUBILANT PHARMOVA

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 JUBLPHARMA is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF JUBILANT PHARMOVA

 
Valuation Score
[As on : Jun 29,2022 ]

Ratio Consolidated
P/E
P/B
P/S
6.59
P/E Calculated based on EPS of 52.51
[ Mar2021 - Consolidated Results ]

1.16
P/B Calculated based on Book Value of 297.84
[ Mar2021 - Consolidated Results ]

0.9
P/S Calculated based on Revenues of 6130.16 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights 💡 JUBLPHARMA is one of the potential top 22% undervalued companies ! Discover More →

FAIR VALUE OF JUBILANT PHARMOVA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-58%
-42%
-39%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF JUBILANT PHARMOVA



JUBILANT PHARMOVA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF JUBILANT PHARMOVA

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.38
0.75
0.73
0.62
0.55
0.83
1.01
0.8
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF JUBILANT PHARMOVA

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF JUBILANT PHARMOVA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
16.56%
27.34%
48.62%
13.75%
-3.31%
-33.97%
-56.78%
-63.53%
QtrlyTrend
0
Latest Qtr: Mar2022
Quarterly Result Analysis →


JUBILANT PHARMOVA related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 4.5% -4.9% 0.1%
S&P BSE 250 SMALLCAP 4.1% -5.3% -3.1%
S&P BSE MIDSMALLCAP 3.9% -4.9% -0.9%
S&P BSE 400 MIDSMALLCAP 3.9% -5.2% -0.8%
S&P BSE ALLCAP 3% -5.2% -0.1%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 3.9% -5.5% -2.6%
NIFTY MID SMALL400 3.8% -5% -0.5%
NIFTY500 MULTICAP 50:25:25 3.2% -5.2% -0.5%
NIFTY 500 2.8% -5.2% -0.4%

You may also like the below Video Courses


FAQ about JUBILANT PHARMOVA


Is JUBILANT PHARMOVA good for long term investment?

As on Jun 29,2022, the Fundamentals of JUBILANT PHARMOVA look Strong and hence it may be good for long term investment! See Financial Performance of JUBILANT PHARMOVA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is JUBILANT PHARMOVA UnderValued or OverValued?

As on Jun 29,2022, JUBILANT PHARMOVA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of JUBILANT PHARMOVA ?

As on Jun 29,2022, the Intrinsic Value of JUBILANT PHARMOVA is Rs. 594.58 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 824.61
Fair Value [Median EV / Sales Model] : Rs. 594.58
Fair Value [Median Price / Sales Model] : Rs. 566.64
Median Fair Value of JUBILANT PHARMOVA : Rs. 594.58

Is JUBILANT PHARMOVA trading at a Premium or Discount?

As on Jun 29,2022, JUBILANT PHARMOVA is trading at a Discount of -42% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].